• Search
  • Helpdesk
  • Sales contact

Decentralized trials

How to avoid common pitfalls when implementing DCT solutions in your clinical trials?

In this episode, Ally Hochman, Clinical Operations Project Manager at Kayentis, offers valuable insights into enhancing technology adoption, establishing enduring relationships with clinical trial stakeholders, and managing multiple data sources...

Decentralized trials: keys to achieving success

What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?...

DCT and health disparities: Insights from a patient advocate

Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor,...

We co-organized the France Biotech Symposium on Decentralized Clinical Trials in Paris!

Date: October 18Location: PariSanté Campus in ParisOBJECTIVES:Define decentralized clinical trials, provide an update on their development and implementation in France...

“DCT is not the goal, just the means” webinar

Using technology to add flexibility to clinical trials can support patients and sites – but a thoughtful consideration of the...

DCT trials

The added value of a single platform DCT trials means bringing the study to the patient’s environment instead of asking...

Key considerations for the implementation of successful Decentralized Clinical Trials (DCTs)

Many chronic diseases such as invasive cancers, inflammatory disorders, cardiovascular, or central nervous system diseases can have a significant impact...

3 good reasons to adopt Decentralized Clinical Trials (DCT)

The clinical trials industry has been facing numerous and long-lasting challenges of patient recruitment and retention, patient compliance, and clinical...